Investigation Report on China Ranibizumab Market, 2012-2019

Publisher Name :
Date: 24-Jul-2015
No. of pages: 20

As macular is the area responsible for high-resolution vision near the center of the retina, macular degeneration, once occurred, will lead to a loss of central vision and distorted vision in the form of metamorphopsia or even irreversible blindness. According to a report published by WHO in 2012, 30 million people suffer from macular degeneration globally, among which about 500,000 end up in blindness per year. In the US, blindness cases caused by macular degeneration outnumbers those caused by glaucoma, cataract and diabetic retinopathy. According to a Chinese investigation in 2012, the incidence of macular degeneration reaches up to 15.5% among old people aged above 50 and 20.2% among those aged above 70. With ageing population, the incidence of macular degeneration will continue to go up.

Developed by Novartis, ranibizumab was approved by CFDA to treat wet age-related macular degeneration (AMD) in 2012. Currently, only Lucentis, a product of Novartis, is available in the Chinese market. However, in Dec. 2013, as the first self-developed drug for the treatment of wet AMD in China, conbercept ophthalmic injection got CFDA's approval.

Ranibizumab develops fast after entering China, sales value in 19 sample hospitals in key cities in 2014 reaching CNY 245 million with a year-on-year growth of 26.29% and CAGR during the last three years reaching 200%. With ageing population, the incidence of macular degeneration goes up gradually. Hence the vast demand for ranibizumab in China. Currently, ranibizumab injections in mainland China all come from Novatis. But as conbercept ophthalmic injection is proved by the clinical studies to improve vision better with a lower administration frequency, it is expected to break the monopoly of Novatis in the wet AMD drug market in the next few years.

Readers can get at least the following information from this report:


  • market size of ranibizumab in China

  • competitive landscape of ranibizumab in Chinese market

  • price of ranibizumab made by different enterprises in China

  • market outlook of ranibizumab in China


The author suggests the following groups of people purchase this report:


  • manufacturers of monoclonal antibody

  • manufacturers of ophthalmic drugs

  • investors/ research institutions interested in Chinese medicine market

  • any interest in the Chinese medicine market, please contact CRI for customized survey service


Companies Mentioned

Novartis

Investigation Report on China Ranibizumab Market, 2012-2019

Table of Contents

1 Related Concepts of Ranibizumab
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Ranibizumab in China
2.1 Patent Status and Approval Information of Ranibizumab in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Ranibizumab in China, 2012-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Ranibizumab in China, 2012-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Ranibizumab in China, 2012-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Ranibizumab in Chinese Hospitals in 2014

7 Major Manufacturers of Ranibizumab in Chinese Market, 2012-2014

8 Market Outlook of Ranibizumab in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Charts

Chart Patent Status of Ranibizumab in China
Chart Registration Information of Ranibizumab in China
Chart Sales Status of Ranibizumab in China
Chart Sales Value of Ranibizumab in China, 2012-2014
Chart Sales Value of Ranibizumab in Some Regions in China, 2012-2014
Chart Sales Volume of Ranibizumab in China, 2012-2014
Chart Sales Volume of Ranibizumab in Some Regions in China, 2012-2014
Chart Price of Ranibizumab Made by Novartis in Some Chinese Cities in 2014

  • Juvenile Macular Degeneration Treatment Market Insights 2019, Global and Chinese Scenario
    Published: 17-Jan-2019        Price: US 3000 Onwards        Pages: 142
    Juvenile Macular Degeneration Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Juvenile Macular Degeneration Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Juvenile Macular Degeneration Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides......
  • Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
    Published: 15-Jan-2019        Price: US 2000 Onwards        Pages: 60
    Introduction DelveInsight's, "Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Uveitis . The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed Products for Uveitis Coverage of API manufacturers for Uvei......
  • Blepharitis - Pipeline Insight, 2019
    Published: 15-Jan-2019        Price: US 1250 Onwards        Pages: 50
    "Blepharitis - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Blepharitis development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered......
  • Viral Conjunctivitis - Pipeline Insight, 2019
    Published: 15-Jan-2019        Price: US 1250 Onwards        Pages: 50
    "Viral Conjunctivitis - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Viral Conjunctivitis development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipelin......
  • Uveal Melanoma - Epidemiology Forecast to 2028
    Published: 15-Jan-2019        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "Uveal Melanoma - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Uveal Melanoma epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2028 Uveal Melanoma Epidemiology The epidemiology section covers th......
  • Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Insight, 2019
    Published: 15-Jan-2019        Price: US 1250 Onwards        Pages: 50
    "Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Juvenile Macular Degeneration (Stargardt Disease) development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route o......
  • Wet Macular Degeneration - Epidemiology Forecast to 2028
    Published: 15-Jan-2019        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "Wet Macular Degeneration - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Wet Macular Degeneration epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2028 Wet Macular Degeneration Epidemiology The ......
  • Leber's Hereditary Optic Neuropathy - Pipeline Insight, 2019
    Published: 15-Jan-2019        Price: US 1250 Onwards        Pages: 50
    "Leber's Hereditary Optic Neuropathy - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Leber's Hereditary Optic Neuropathy development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecul......
  • Retinal Vein Occlusion - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
    Published: 15-Jan-2019        Price: US 2000 Onwards        Pages: 60
    Introduction DelveInsight's, "Retinal Vein Occlusion - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Retinal Vein Occlusion . The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed Products for Retinal Vein Occlusion......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs